Zogenix’s $200 Million Convertible Senior Notes Offering

Latham & Watkins LLP represented Zogenix in the offering. Zogenix, Inc., a global biopharmaceutical company, has announced the pricing of its offering of US$200 million aggregate…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here